Live
- ChatGPT and Sora Outage: Services Restored After Hours of Downtime
- WhatsApp iOS Update: WhatsApp Brings AR Effects, Video Backgrounds and Document Scanning
- The advantages of buying a luxury villa in a community development
- Mufasa: The Lion King Roars to Success with INR 74 Crores in Its Opening Week in India
- CM Revanth Reddy Expresses Grief Over the Demise of Dr. Manmohan Singh
- Virat Kohli Encountered by Fan During Melbourne Test: Security Rushes In
- Telugu cinema struggling in the absence of Dasari
- Allu Arjun to Appear in Virtual Court Hearing Along with Sureties in Sandhya Theatre Case
- Today’s Horoscope: How December 27, 2024 Aligns for Each Zodiac Signs
- Allu Arjun to Attend Nampally Court Hearing Online Following Security Reasons
Granules India arm gets USFDA nod for an antiviral
Highlights
Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
Hyderabad: Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a-wholly owned foreign subsidiary of Granules India Ltd for Valganciclovir hydrochloride for oral solution, 50 mg/ml," the company said in a regulatory filing.
Next Story
ADVERTISEMENT
